Digibind reverses inhibition of cellular Rb+ uptake caused by endogenous sodium pump inhibitors present in serum and placenta of women with preeclampsia

Reproductive Sciences

Volumn 18, Issue 2, 2011, Pages 190-199

  Hopoate Sitake, Moana L ^a   Adair, C David ^b   Mason, Lorrie A ^b   Torres, Carlos ^b   Kipikasa, Joseph ^b   Graves, Steven W ^a  

^a Brigham Young University   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Hypertension; Ion transport; K ATPase; Na; Preeclampsia

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DIGITALIS LIKE FACTOR; DIGOXIN ANTIBODY F(AB) FRAGMENT; OUABAIN; RUBIDIUM ION;

ARTICLE; BLOOD SAMPLING; CELL TRANSPORT; CONTROLLED STUDY; DRUG PROTEIN BINDING; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ION TRANSPORT; MYOMETRIUM; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY;

BLOOD PROTEINS; CARDENOLIDES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; IMMUNOGLOBULIN FAB FRAGMENTS; MYOMETRIUM; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RUBIDIUM; SAPONINS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 79952516143     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110385133     Document Type: Article

References (47)

1. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008;21(5):521-526.
2. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183(1):S1-S22.
3. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-192. (Pubitemid 36792143)
4. Sibai B, Dekker G, Kupfermine M. Pre-eclampsia. Lancet. 2005;365(9461):785-799.
5. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obset Gynecol. 2000;95(1):24-28.
6. Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186(1):66-71. (Pubitemid 34093742)
7. Haddy FJ, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci. 1976;19(7):935-947.
8. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977;232(5):C165-C173. (Pubitemid 8134015)
9. Graves SW, Williams GH. Endogenous digitalis-like natriuretic factors. Annu Rev Med. 1987;38:433-444.
10. Hollenberg NK, Graves SW. Endogenous sodium pump inhibition: current status and therapeutic opportunities. Prog Drug Res. 1996;46:9-42. (Pubitemid 26179960)
11. Goto A, Yamada K. Ouabain-like factor. Curr Opin Nephrol Hypertens. 1998;7(2):189-196. (Pubitemid 28116660)
12. Graves SW, Eder JP, Schryber SM, et al. Endogenous digoxinlike immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation. Clin Sci. 1989;77(5):501-507. (Pubitemid 19257716)
13. Blaustein MP, Hamlyn JM, Pallone TL. Sodium pumps: ouabain, ion transport, and signaling in hypertension. Amer J Physiol. 2007;293(1):F438. (Pubitemid 47345045)
14. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism and cell growth. Am J Physiol Cell Physiol. 2007;293(2):C509-C536. (Pubitemid 47235171)
15. Nesher M. Shpolansky U, Rosen H, Lichtstein D. The digitalislike steroid hormones: new mechanisms of action and biological significance. Life Sci. 2007;80(23):2093-107. (Pubitemid 46755329)
16. Hamlyn JM, Blaustein MP, Bova S, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A. 1991;88(14):6259-6263. (Pubitemid 21914926)
17. Graves SW, Brown B, Valdes R Jr. An endogenous digoxin-like substances in patients with renal impairment. Ann Int Med. 1983;99(5):604-608. (Pubitemid 14235391)
18. Krep H, Price DA, Soszynski P, Tao Q-F, Graves SW, Hollenberg NK. Volume sensitive hypertension and the digoxin-like factor: reversal by an Fab directed against digoxin in DOCA-salt hypertensive rats. Am J Hypertens. 1995;8(9):921-927.
19. Krep HH, Graves SW, Price DA, et al. Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with Digibind: stoichiometry and its implications. Am J Hypertens. 1995;9(1):39-46.
20. Smith TW, Lloyd BL, Spicer N, Haber E. Immunogenicity and kinetics of distribution and elimination of sheep digoxinspecific IgG and Fab fragments in the rabbit and baboon. Clin Exp Immunol. 1979;36(3):384-396. (Pubitemid 9192684)
21. Graves SW. Sodium regulation, sodium pump function and sodium pump inhibitors in uncomplicated pregnancy and preeclampsia. Front Biosci. 2007;12:2438-2446.
22. Hickey AR, Wenger TL, Carpenter VP, et al. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol. 1991;17(3):590-598.
23. Goodlin RC. Antidigoxin antibodies in eclampsia. N Engl J Med. 1988;318(8):518-519. (Pubitemid 18054305)
24. Adair CD, Backalew VM, Taylor K, et al. Elevated endoxin-like factor complicating a second trimester pregnancy: treatment with digoxin-binding immunoglobin. Am J Nephrol. 1996;6(6):529-531. (Pubitemid 26387940)
25. Adair CD, Luper A, Rose JC, Russell G, Veille JC, Buckalew VM. The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind randomized, clinical trial. J Perinatolog. 2009;29(4):284-289.
26. Adair CD, Buckalew VM, Graves SW, et al. Digoxin immune Fab treatment for severe preeclampsia. Am J Perinatol. 2010;27(8):655-662.
27. Agunanne E, Horvat D, Uddin MN, Puschett J. The treatment of preeclampsia in a rat model employing Digibind. Am J Perinatol. 2010;27(4):299-305.
28. Horvat D, Severson J, Uddin MN, Mitchell B, Puschett JB. Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome. Hypertens Pregnancy. 2010;29(1):1-9.
29. National Institutes of Health Working Group on Hypertension in Pregnancy. Classification of Hypertensive Disorders of Pregnancy. Bethesda, MD: US Dept of Health and Human Services; 1991.
30. Zhen Y, Franz KB, Graves SW. A novel assay of cell rubidium uptake using graphite furnace atomic absorption: application to rats on a magnesium deficient diet. J Nutr Biochem. 2005;16(5):291-296. (Pubitemid 41556918)
31. Diamandis EP, Papanastaslou-Diamandi A, Soldin SJ. Digoxin immunoreactivity in cord and maternal serum and placental extracts. Partial characterization of immunoreactive substances by high-performance liquid chromatography and inhibition of Na+,K+-ATPase. Clin Biochem. 1985;18(1):48-55.
32. Morris JF, Poston L, Wolfe CD, Hilton PJ. A comparison of endogenous digoxin-like immunoactivity and sodium transport inhibitory activity in umbilical arterial and venous serum. Clin Sci (Lond). 1988;75:577-579. (Pubitemid 19015436)
33. Hilton PJ, White RW, Lord GA, et al. An inhibitor of the sodium pump obtained from human placenta. Lancet. 1996;348(9023):303-305. (Pubitemid 26254631)
34. Gao S, Chen Z, Xu Y. The source of endogenous digitalis-like substance in normal pregnancy. Zhonghua Fu Chan Ke Za Zhi. 1998;33(9):539-541.
35. Fedorova OV, Tapilskaya NI, Bzhelyansky AM, et al. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae. J Hypertens. 2010;28(2):361-366.
36. Stewart L, Hamilton C, Ingwall J, et al. Vascular smooth muscle response to ouabain: relation of tissue sodium to the contractile response. Circ Res. 1993;73(6):1113-1120. (Pubitemid 23340206)
37. Dostanic I, Paul RJ, Lorenz JN, Theriault S, Van Huysse JW, Lingrel JB. The alpha2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol. 2005;288(2):H477-H485. (Pubitemid 40139628)
38. Li SQ, Eim C, Kirch U, Lang RE, Schoner W. Bovine adrenals and hypothalamus are a major source of proscillaridin A and ouabain immunoreactivities. Life Sci. 1998;62(11):1023-1033. (Pubitemid 28085576)
39. Bagrov AY, Fedorova OV, Dmitrieva RI, et al. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension. 1998;31(5):1097-1103. (Pubitemid 28191503)
40. Goto A, Ishiguro T, Yamada K, et al. Isolation of a urinary digitalis-like factor indistinguishable from digoxin. Biochem Biophys Res Commun. 1990;173(3):1093-1101.
41. Fedorova OV, Simbirtsev AS, Kolodkin NI, et al. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension. J Hypertens. 2008;26(12):2414-25.
42. Tao QF, Hollenberg NK, Price DA, Graves SW. Sodium pump isoform specificity for the digitalis-like factor isolated from human peritoneal dialysate. Hypertension. 1996;29(3):815-821.
43. Bagrov AY, Fedorova OV. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries. J Hypertens. 1998;16(12 pt 2):1953-1958. (Pubitemid 29002373)
44. Wang Y, Lewis DF, Adair CD, Gu Y, Mason L, Kipikasa JH. Digibind attenuates cytokine TNFα-induced endothelial inflammatory response: potential benefit role of Digibind in preeclampsia. J Perinatol. 2009;29(3):195-200.
45. EsplinMS, FausettMB, Faux DS, Graves SW. Changes in the isoforms of the sodium pump in the placenta and myometrium of women in labor. Am J Obstet Gynecol. 2003;188(3):759-764. (Pubitemid 36332447)
46. Vance CJ, Esplin MS, Hamblin S, Graves SW. Alterations in uterine sodium pump abundance may contribute to the onset and progression of term and preterm labor in mice. Am J Obstet Gynecol. 2006;195(5):1407-1414. (Pubitemid 44635375)
47. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-1594. (Pubitemid 40807500)